[Skip to Navigation]
Sign In
JAMA Network Clinical Guideline Synopsis
July 7, 2021

Review of Clinical Practice Guideline: Nosebleed (Epistaxis)

Author Affiliations
  • 1Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut
JAMA Surg. 2021;156(10):974-975. doi:10.1001/jamasurg.2021.2873

More than 60% of the US population have experienced epistaxis (nosebleeds) in their lifetime, of whom 6% will seek medical attention.1 Depending on the severity, nosebleeds can be costly and heavily affect quality of life.1 The range of interventions for epistaxis includes self-treatment and/or home remedies, moderately invasive (sometimes only temporizing) clinician-based interventions, and surgical or endovascular procedures. The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) created this guideline for nosebleeds that are severe, persistent, and/or recurrent to provide clear, actionable recommendations and reduce variations in the management of epistaxis.

Add or change institution
×